Corporate Governance Report 2024

We are committed to the highest principles of good corporate governance, which we believe will provide a sustainable framework for realizing our strategy and objectives while at the same time strengthening our relationship with shareholders, employees, customers, suppliers and other stakeholders. Through accountability, transparency, fairness and responsibility, we strive to create an appropriate balance between management and control in alignment with the interests of our stakeholders.

Our Corporate Governance Report 2024 provides information on corporate governance in accordance with the SIX Swiss Exchange Directive on Information relating to Corporate Governance (“DCG”), the Swiss Code of Obligations (“CO”) and the principles of the Swiss Code of Best Practice for Corporate Governance issued by economiesuisse.1 The information contained herein generally follows the structure of the annex of the DCG.

All information within this Corporate Governance Report 2024 refers to the Company’s organization, Articles of Association2 and Organizational Regulations3 that were in effect as of 31 December 2024 (unless otherwise stated).

1 In its version as approved by the board of economiesuisse on 14 November 2022.
2 PolyPeptide Group AG’s Articles of Association are available at www.polypeptide.com/investors/results-center/results-2024/.
3 PolyPeptide Group AG’s Organizational Regulations are available at www.polypeptide.com/investors/results-center/results-2024/.